Navigation Links
Otonomy Enrolls First Patient in Pivotal Phase 2b Study of OTO-104 in Meniere's Disease
Date:12/11/2013

SAN DIEGO, Dec. 11, 2013 /PRNewswire/ -- Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced enrollment of the first patient in its pivotal Phase 2b study of OTO-104 for the reduction of vertigo in patients with unilateral Meniere's disease. The company also announced that the U.S. Food and Drug Administration (FDA) has granted OTO-104 Fast Track designation, a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need.

(Logo: http://photos.prnewswire.com/prnh/20130806/MM59802LOGO)

This prospective, randomized, double-blind, placebo-controlled Phase 2b study is designed to assess the efficacy and safety of OTO-104 for the treatment of Meniere's disease in a total of 140 patients at approximately 50 centers in the United States and Canada. The primary endpoint is the reduction in vertigo frequency at week 12, measured during the 4-week interval from week 9 through week 12, compared to baseline. Otonomy expects to complete patient enrollment of the trial by mid-2014 and announce top line results during the fourth quarter of 2014.

"The commencement of enrollment marks an important clinical milestone for the advancement of OTO-104 as we expect this trial will serve as one of the two studies required to demonstrate efficacy for approval in the United States," said David A. Weber, Ph.D., president and CEO of Otonomy. "The FDA's Fast Track designation shows that the agency recognizes the potential for this product to address the important unmet medical need in Meniere's disease."

Added Paul R. Lambert, M.D., professor and c
'/>"/>

SOURCE Otonomy, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Otonomy Completes $45.9 Million Series C Equity Financing
2. Otonomy Acquires Assets and Patent Rights for Tinnitus Program
3. CalHIPSO Enrolls Over 7,700 Providers in EHR Implementation Program, Hits Other Key Milestones After First Two Years
4. Boehringer Ingelheim Enrolls First Patients in Pivotal Phase 3 Interferon-Free Hepatitis C Trial Program
5. Adynxx Enrolls First Patient in Phase 2 Proof-of-Concept Study for AYX1, Lead Compound for the Prevention of Post-Surgical Pain
6. ROX Medical enrolls first patients in Ireland for CONTROL-HTN hypertension trial at Beaumont and Mater Private Hospitals
7. ROX Medical enrolls first UK patients in CONTROL-HTN hypertension trial at Eastbourne General Hospital
8. Intarcia Enrolls First Patients in "FREEDOM" Global Phase 3 Program for ITCA 650 in Type 2 Diabetes
9. Barts Hospital, London enrolls first patients in ROX Medicals CONTROL-HTN resistant hypertension trial
10. Epizyme Enrolls First Patient in Phase 1/2 Clinical Trial of EPZ-6438, an Inhibitor of EZH2
11. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014  Grammy Award-winner Bruce Hornsby will ... philanthropists, athletes, actors, and musicians during the 10 th ... at the Mandarin Oriental Hotel in New ... honor six individuals who embody the values of the ... its highest honor, the Spirit of an Active Lifestyle ...
(Date:10/31/2014)... Imago BioSciences, Inc., a biotech company ... Series A financing led by Clarus Ventures LLC, ... of accomplished investment and operating professionals dedicated to ... include Frazier Healthcare, Amgen Ventures, and Merck Research ... Frazier Healthcare will join the company,s board of ...
(Date:10/31/2014)... Investor-Edge has initiated coverage on ... ), Isis Pharmaceuticals Inc. (NASDAQ: ISIS ), ... Pharmaceuticals Inc. (NASDAQ: ACAD ), and Synta ... companies can be accessed at: http://investor-edge.com/register . ... ended at 4,566.14, up 0.37%, the Dow Jones Industrial ...
Breaking Medicine Technology:10th Anniversary Orthopaedic Foundation Gala Set For Success 2Imago BioSciences Announces $26.5 Million Financing Led by Clarus Ventures 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5
... WORTH, Texas, March 3, 2011 A new report ... residents of 12 counties in East Texas are breathing a ... conducted by the health science center,s Center for Professional ... chronic obstructive pulmonary disease (COPD).  The report shows ...
... March 3, 2011 AORN Works , a ... announced that its market research and surgical insights division ... (Logo: http://photos.prnewswire.com/prnh/20101001/DC75398LOGO ) ... attitudes of perioperative professionals who are the end users ...
Cached Medicine Technology:Educational Efforts Reduce COPD Costs by $3.4 Million in East Texas Study 2Educational Efforts Reduce COPD Costs by $3.4 Million in East Texas Study 3Educational Efforts Reduce COPD Costs by $3.4 Million in East Texas Study 4Advanced Market Research for Medical Device Manufacturers 2
(Date:10/31/2014)... Chico, CA. (PRWEB) October 31, 2014 ... best known for its small scale BioPro™ biodiesel ... equipment that will further improve the performance and ... , The GL95/MC12/BD380 trio will recover ... is mixed in with the glycerin by-product produced ...
(Date:10/31/2014)... Research Center for Healthy Neighborhoods (PRCHN) at Case ... key player in nearly $13.32 million in federal ... Ohio. , The Centers for Disease Control and ... million over five years. The funds will support ... disseminating individual, environmental, and policy interventions that prevent ...
(Date:10/31/2014)... Colorado (PRWEB) October 31, 2014 The Memory ... was created by Alexander Lynch, whose father suffered from Alzheimer's ... a dramatic moment, caused by his father's disease. His father ... That was the crucial moment when the author of this ... his dad. , The Memory Healer program is based ...
(Date:10/31/2014)... 2014 Monica Williams-Murphy MD , ... too well the chaos that can occur for people ... vast majority of Americans who come into the emergency ... completely unprepared for the moment and so are their ... serve as a catalyst for a family to get ...
(Date:10/31/2014)... Summit, Missouri (PRWEB) October 31, 2014 ... the country about families narrowly escaping carbon monoxide poisoning ... season) looms just weeks away, one family-owned, Missouri-based heating ... straightforward approach to making sure families start the home ... are safe and secure. , Beginning Nov. 1, ...
Breaking Medicine News(10 mins):Health News:Springboard Biodiesel Announces Release of New and Unique Methanol Recovery and Glycerin Treatment Equipment 2Health News:Springboard Biodiesel Announces Release of New and Unique Methanol Recovery and Glycerin Treatment Equipment 3Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 2Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 3Health News:"Memory Healer" Review Reveals a New Natural Remedy Guide for Managing Memory Loss 2Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 2Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 3Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3
... at the Imperial College London it was found that lab ... , It was believed that early exposure to ... lab workers who frequently handled research rodents had fewer allergic ... to be protective against eczema allergy. The study results are ...
... a stroke, caused either by a blocked or burst blood vessel ... die. ,That's the bad news. ,And the good news! ... problems that cause many strokes — before a stroke ever happens. ... the skull. ,New technologies, delivered to the brain via ...
... who is now 42 years old has been slightly unconscious and ... His nerves were completely sheared in a car crash and he ... others by means of grunts and nods. But now his speech ... the tiny nerve connections in his brain slowly started to rewire. ...
... conducted by the Korean scientists from the Korea Research Institute of ... that the research team has found a human gene that aids ... The researchers were very happy about the discovery and said that ... cancers. ,The study was mainly conducted on mice and ...
... Haryana Government has decided to start a two year ... in Panchakarma at Shri Krishna Government// Ayurvedic College at ... diploma courses has already been formulated and these courses ... state Health Minister Kartar Devi told reporters here., ...
... to be far from the goal of any reversal of the ... in cases of drug abuse in all of Europe//. The statistics ... abuse category and a rank 3 in cocaine and ecstasy abuse. ... abuse. ,As per the drug policy of the government, ...
Cached Medicine News:Health News:Brain Surgery Without the Surgery? 2Health News:Brain Surgery Without the Surgery? 3Health News:Brain Surgery Without the Surgery? 4Health News:Brain Surgery Without the Surgery? 5Health News:Brain Surgery Without the Surgery? 6
... SAFE-T-FILL Capillary Blood Collection Tubes are 100% ... a wide range of applications, the Capillary ... tube, attached cap and a micro tube.,The ... the blood into the micro tube thereby ...
... Scientifics SAFE-T-FILL Capillary Blood Collection Tubes are ... for a wide range of applications, the ... capillary tube, attached cap and a micro ... draw the blood into the micro tube ...
... The Bio-Rad Mumps IgG test is an ... Test results are obtained after a 90-minute incubation. ... index values, permitting uniformity of reporting. The ... qualitative and semi-quantitative detection of human IgG antibodies ...
... Bio-Rad Measles IgG test is an enzyme immunoassay ... are obtained after a 90-minute incubation. The ... permitting uniformity of results. The Bio-Rad Measles ... semi-quantitative detection of human IgG antibodies to measles ...
Medicine Products: